Delivery Order SPE2DB22D2211-SPE2DB25FRUYW

Award Date 4/9/25
Potential Completion Date 4/10/25
Potential Value $31K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,809.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Freestyle Libre 3 Sensors, a medical device used for diabetes management, with a completion date of June 12, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award, valued at $1,042.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Freestyle Libre 3 Sensors, a medical device used for diabetes management. The contract has an ultimate completion date of January 3, 2025 and is structured as a firm fixed-price delivery order. This award is not associated with a set-aside designation, indicating...
This federal contract award, valued at $2,207.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Freestyle Libre 3 Sensors, a medical device used for diabetes management. The contract is a Firm Fixed Price Delivery Order with a period of performance through November 24, 2023. It is not designated as a set-aside contract. Amerisourcebergen holds a larger...
This federal contract award, valued at $7,430.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Freestyle Libre 3 Sensors, which are medical devices used for glucose monitoring. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 6, 2025. It is not designated as a set-aside contract....
This federal contract award, valued at $4,508.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Freestyle Libre 3 Sensors, which are medical devices used for diabetes management. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 6, 2025. There is no set-aside designation indicated for this award....
This federal contract award, valued at $6,052.11, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Freestyle Libre 3 sensors, which are medical devices used for glucose monitoring. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $1,232.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Freestyle Libre 3 Sensors, a medical device used in the management of diabetes. The contract has an ultimate completion date of March 13, 2025 and is a firm fixed price delivery order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
This federal contract award, valued at $2,534.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Freestyle Libre 3 Sensors, a medical device used for diabetes management, with a completion date of February 18, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop...
This federal contract award, valued at $2,120.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,992 units of Freestyle Libre 3 Sensors, a medical device used for diabetes management. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 23, 2025. The contract is not set aside for any specific type of business....
This federal contract award, valued at $1,536.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which has a completion date of January 29, 2025, is for the delivery of Freestyle Libre 3 sensors, a medical device used for diabetes management. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRUYW
    Delivery Order

This federal contract award, valued at $30,602.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Freestyle Libre 3 Sensors, a medical device used for diabetes management. The contract has an ultimate completion date of April 10, 2025, and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/9/25, 10:08 AM